LocalPlus
Open Access Plus
Cigna PPO
Cigna HMO
Dr. Nzota Nsona Koyagialo, MD
Internal Medicine*
Age 46
Be the first to review this provider!
Link Copied!
Profile link copied to clipboard!
Link Copied!
Profile link copied to clipboard!
Dr. Nzota Nsona Koyagialo, MD
Be the first to review this provider!
Kennesaw, GA
Accepting new patients
Clinical Overview
Dr. Nzota Nsona Koyagialo, MD works in Kennesaw, GA as
COMPARE OTHER TOP Internal Medicine Doctors
Contrast Dr. Nsona Koyagialo with other nearby specialists.
Mavis Appiah Kubi, NP
Learn More
Dr. Anita Varkey, MD
Learn More
Maryah Truss, NP
Learn More
Dr. Baoquang Le, DO
Learn More
Kimberly Miller, NP
Learn More
These providers are on the medical staff of Oak Street Health.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Navigate HMOChoice Plus POSNavigate Plus POSOptions PPO
-
Elect Choice (Open Access) EPOAetna HMOOpen Choice PPOManaged Choice (Open Access) POSPremier Care Network Plus - Innovation HealthAPCN Choice POS IIChoice Plus POS II
-
HealthyBlue Advantage
-
Blue Open Access Alternate Network POS
-
BlueCard PPO
-
Pathway HMOBlue Choice PPOBlue Choice Option POSBlue Choice HMOBlue Open Access POS
-
Superior Health Plan
Office Locations
-
Aylo Health - Primary Care at Kennesaw2985 Mack Dobbs Rd NW, Kennesaw, GA 30152
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Nsona Koyagialo?
Step 1 of 3
Your review of Dr. Nzota Nsona Koyagialo, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Languages Spoken
French
Specialties*
Internal Medicine
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Nzota Nsona Koyagialo, MD accepts new patients on Medical News Today.
Dr. Nsona Koyagialo accepts Cigna, UnitedHealthCare, Aetna, CareFirst BlueCross BlueShield, Anthem, Blue Cross Blue Shield, Blue Cross Blue Shield of Georgia and Ambetter as well as many others. See all of the insurances Dr. Nsona Koyagialo accepts here.
Dr. Nsona Koyagialo's office is located at 2985 Mack Dobbs Rd NW Kennesaw, GA 30152. Get a map and directions to Dr. Nsona Koyagialo's office here.
Yes, Dr. Nsona Koyagialo speaks French. See Dr. Nsona Koyagialo's profile on MedicalNewsToday for more information.
Dr. Nsona Koyagialo does not have any reviews yet.
Dr. Nsona Koyagialo is board certified in
Education & Credentials
Medical Education
- Augusta University Medical College of Georgia
Board Certifications
- Family Practice
Claim Your Profile
Are you Dr. Nzota Nsona Koyagialo, MD?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A real world study suggests found that more than three-quarters of participants receiving the anti-amyloid drug Leqembi either remained clinically stable or improved by one disease stage.
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Up to 45% of dementia cases globally could be delayed or even prevented by acting on modifiable risk factors, new WHO guidelines show.
Explore More Providers
- Arterial Blood Gas Test (ABG)
- Electrocardiogram (EKG)
- Advance Directive End of Life Planning
- Care Coordination for Complex Conditions and Procedures
- Immunization Administration
